Seven of them were on antibiotic prophylaxis with cotrimoxazole (AT2–4, AT9–10, AT16–17), one patient was on penicillin prophylaxis for a previous diagnosis of rheumatic disease (AT4), and four were receiving immunoglobulin replacement therapy (AT3, AT9, AT17, and ATF A). This evidence concerns the gene AATF and rheumatic disorder.